Trump administration review impacts Global Fund financing

The Trump administration’s review of foreign aid has placed the funding trajectory of the Global Fund to Fight AIDS, Tuberculosis and Malaria under intense scrutiny. Executive-level evaluations of international assistance programs may alter multilateral health commitments, potentially impacting global supply chains for essential therapeutics and diagnostic interventions.

According to the World Health Organization, sustained financing is vital for maintaining viral suppression rates and preventing drug-resistant strains of tuberculosis. Disruptions in donor contributions could affect the distribution of antiretroviral therapy, tuberculosis medications, and insecticide-treated nets. Such shifts in funding models risk disrupting pharmaceutical distribution, diagnostic screening programs, and clinical trial access in high-burden regions.